




Searching News Database: Hedgehog
HSMN NewsFeed - 26 Apr 2013
Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European Union
Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European Union
HSMN NewsFeed - 26 Mar 2013
ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma
ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma
HSMN NewsFeed - 28 Nov 2012
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
HSMN NewsFeed - 28 Nov 2012
Curis Announces $30 Million Secured Debt Financing to Support Development of Proprietary Pipeline
Curis Announces $30 Million Secured Debt Financing to Support Development of Proprietary Pipeline
HSMN NewsFeed - 9 Nov 2011
FDA Accepts Genentech’s New Drug Application For Vismodegib in Advanced Form of Skin Cancer
FDA Accepts Genentech’s New Drug Application For Vismodegib in Advanced Form of Skin Cancer
HSMN NewsFeed - 8 Nov 2011
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
HSMN NewsFeed - 15 Sep 2011
Curis, Inc. Announces Appointment of Robert Martell, M.D., Ph.D. to its Board of Directors
Curis, Inc. Announces Appointment of Robert Martell, M.D., Ph.D. to its Board of Directors
HSMN NewsFeed - 12 Sep 2011
Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer
Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer
HSMN NewsFeed - 11 Apr 2011
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
HSMN NewsFeed - 28 Oct 2008
Infinity Announces the Promotion of Adelene Q. Perkins to President and Chief Business Officer
Infinity Announces the Promotion of Adelene Q. Perkins to President and Chief Business Officer
HSMN NewsFeed - 14 Mar 2008
Genentech Provides Business Update at Annual Investment Community Meeting
Genentech Provides Business Update at Annual Investment Community Meeting
HSMN NewsFeed - 22 Jan 2008
Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway
Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway
HSMN NewsFeed - 19 Dec 2007
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
HSMN NewsFeed - 16 Nov 2006
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
HSMN NewsFeed - 12 Sep 2006
Curis, Inc. Announces New Cancer Programs, Formation of China-Based Subsidiary
Curis, Inc. Announces New Cancer Programs, Formation of China-Based Subsidiary
HSMN NewsFeed - 1 Sep 2006
Curis Determines to Opt Out of Co-Development of Basal Cell Carcinoma Drug Candidate
Curis Determines to Opt Out of Co-Development of Basal Cell Carcinoma Drug Candidate
HSMN NewsFeed - 27 Jun 2006
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
HSMN NewsFeed - 23 May 2006
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
HSMN NewsFeed - 12 Apr 2006
Discovery Partners International and Infinity Pharmaceuticals Announce Merger Agreement
Discovery Partners International and Infinity Pharmaceuticals Announce Merger Agreement
HSMN NewsFeed - 13 Feb 2006
Recruitment Temporarily Suspended in an International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Recruitment Temporarily Suspended in an International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Additional items found! 43

Members Archive contains
43 additional stories matching:
Hedgehog
(Password required)
Hedgehog
(Password required)